A South Africa-based Phase IIIb observational study of Johnson & Johnson’s single-jab Covid-19 vaccine JNJ-78436735 has enrolled at least 18,000 healthcare workers out of its 500,000 target since Wednesday (17...
Long-term Covid-19 vaccine durability has become less of an endgame since it has become increasingly likely additional shots will be…
The US National Institutes of Health (NIH) has reported that the Phase I clinical trial of Regeneron’s two monoclonal antibodies (mAbs) directed against the Middle…
Irish company ICON has agreed to acquire contract research company PRA Health Sciences in a cash and stock deal valued at about $12bn. The acquisition…
Stealth BioTherapeutics has completed enrolment in the Phase II ReCLAIM-2 study (SPIAM-202) of its lead product candidate, elamipretide, in patients…
NeuroRx has reported that the Phase IIb/III trial of Zyesami (aviptadil, previously RLF-100) showed multidimensional benefit in treating respiratory failure…
Yale School of Medicine has announced a randomised clinical trial led by the Yale Cardiovascular Research Group (YCRG) to study…
Specialty biopharmaceutical company RedHill Biopharma is set to expand its global Phase II/III study of opaganib in patients with severe…
No new safety concerns coming out of Phase Ib trial desired to move forward Moving to Phase II, triplet needs to show superiority over rival Targeting specific mutations important for…
Companies and organisations continue to report trial disruptions due to the Covid-19 pandemic, which includes delayed initiation, delayed enrollment, and slow enrollment. As the number of Covid-19 cases and deaths…
As of 15 February, the likelihood of approval (LoA) for Pfizer’s Rapamune (sirolimus) for Sturge-Weber Syndrome (SWS) rose 15 points, according to GlobalData’s LoA data. The score was based on published results…
The COVID-19 pandemic has led to a surge in the use of remote patient monitoring (RPM) tools to monitor patients...
The COVID-19 pandemic triggered unexpected challenges in the business environment prompting pharmaceutical companies to accelerate the adoption of digital transformation strategies.
The COVID-19 pandemic has led to an increase in investments in digital transformation and emerging technologies to deal with the shift towards remote working and...
The UK government has banned Chinese technology firm Huawei from providing telecommunications equipment to the UK’s mobile 5G network from the start of 2021.
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
Neurology trends: Stroke leads Twitter mentions in Q4 2020
The top tweeted terms are the trending industry discussions happening on Twitter by key individuals (influencers) as tracked by the platform. Stroke– 88 mentions Links between Covid-19 and stroke, drugs…